OpenSecrets.org @OpenSecretsDC
Pharmaceutical companies, which stand to lose the pricing power over top-selling drugs as Congress weighs price-setting bills, are writing large checks to key lawmakers and spending millions on ad buying and lobbying. https://t.co/EHeDdPlKuz — PolitiTweet.org